(Q37625591)

21 August 2017

1 reference

title

Adjuvants and autoimmunity (English)

1 reference

21 August 2017

3

M Blank

1 reference

21 August 2017

2

N Agmon-Levin

1 reference

21 August 2017

1

E Israeli

1 reference

21 August 2017

4

Y Shoenfeld

0 references

publication date

1 November 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

18

1 reference

21 August 2017

issue

13

1 reference

21 August 2017

page(s)

1217-1225

1 reference

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

The novel adjuvant IC31 strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Improving vaccine delivery using novel adjuvant systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Immunological concepts of vaccine adjuvant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Inferences, questions and possibilities in Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Toll-like receptors in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Molecular and cellular signatures of human vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Coinoculation with hepatitis B surface and core antigen promotes a Th1 immune response to a multiepitopic protein of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Infection, vaccines and other environmental triggers of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Chronic fatigue syndrome with autoantibodies--the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Induction of Plasma Cell Tumours in BALB/c Mice with 2,6,10,14-Tetramethylpentadecane (Pristane)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Distinctive patterns of autoimmune response induced by different types of mineral oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Antibodies to squalene in Gulf War syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

Vaccine adjuvants: current state and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

New horizons in adjuvants for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

The adjuvant effect in infection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309345724

21 January 2018

Identifiers

DOI

10.1177/0961203309345724

1 reference

21 August 2017

1 reference